Cummings Keith Lamont sold PLRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001746473-26-000012

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 20, 2026

Published

Jan 22, 2026

Ingested by INSIDER

Nov 5, 04:21 UTC

Last re-read

Nov 5, 04:21 UTC

Extracted facts

Filer

Cummings Keith Lamont

Role

Chief Financial Officer

Transaction

Open-market saleAs filed: “S”

Asset

PLIANT THERAPEUTICS, INC.

Ticker

PLRX

Shares

24.0K

Price per share

$1.28

Value

$30,723

Execution date (reported)

Jan 20, 2026

Owned after transaction

297.2K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Cummings Keith Lamont filed this Form 4 reporting a open-market sale of PLRX on Jan 20, 2026. It became public on Jan 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Cummings Keith Lamontcik:0001809204

Issuer

PLIANT THERAPEUTICS, INC.cik:0001746473

Revision history · 0

No field has changed since this record was first ingested.